Clinical pharmacokinetics of dorzolamide.


Dorzolamide is a carbonic anhydrase inhibitor for topical ophthalmic application. It is used in the treatment of glaucoma to lower the intraocular pressure. After absorption via the cornea and stroma, it inhibits carbonic anhydrase in the ciliary process, which leads to a reduction of aqueous humour production and therefore to the desired therapeutic effect… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.